Etonogestrel/ethinyl Estradiol Insert, Extended Release
Product Images NDC 66993-605

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Etonogestrel/ethinyl Estradiol (NDC 66993-605). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Etonogestrel 01)

Figure 1 (Etonogestrel 01)
This appears to be a table showing the number of women with a blood clot out of 10,000 woman-years, divided by different categories including non-CHC users who are not pregnant, postpartum (up to 12 weeks only), and different age ranges.*
FDA Label Image

Etonogestrel 01a

Etonogestrel 01a
FDA Label Image

Chemical Structure (Etonogestrel 02)

Chemical Structure (Etonogestrel 02)
Etonogestrel is a type of hormonal birth control that is inserted under the skin. It is a progestin-only contraceptive that works by thickening the cervical mucus and thinning the lining of the uterus to prevent ovulation and fertilization. It offers long-term contraception for up to three years, and is 99% effective at preventing pregnancy when used correctly.*
FDA Label Image

Chemical Structure (Etonogestrel 03)

Chemical Structure (Etonogestrel 03)
Ethynyl estradiol is a synthetic form of the female hormone estrogen. It is used as a component of most hormonal contraceptive methods. Ethynyl estradiol helps to prevent pregnancy by inhibiting ovulation, thickening cervical mucus to prevent sperm from reaching the egg, and thinning the lining of the uterus to prevent implantation of a fertilized egg. It may also be used to treat certain menstrual disorders and acne.*
FDA Label Image

Figure 2 (Etonogestrel 04)

Figure 2 (Etonogestrel 04)
This text appears to be a label or record related to a medication called Etonogestrel. It includes the name of the medication, a code (EE), and a reference to its use with a vaginal ring. Additionally, it mentions numbers related to days after insertion. It is not possible to determine the full context or purpose of this record without additional information.*
FDA Label Image

Figure (Etonogestrel 05)

Figure (Etonogestrel 05)
This text describes various methods of birth control and their effectiveness. It provides statistics on pregnancy rates and lists the different types of contraceptives such as pills, patches, implants, IUDs, condoms, diaphragms, and fertility awareness methods such as tracking fertile days, spermicide, and withdrawal. It serves as a comprehensive guide to family planning.*
FDA Label Image

Figure (Etonogestrel 06)

Figure (Etonogestrel 06)
FDA Label Image

Figure A (Etonogestrel 07)

Figure A (Etonogestrel 07)
FDA Label Image

Figure B (Etonogestrel 08)

Figure B (Etonogestrel 08)
FDA Label Image

Figure C (Etonogestrel 09)

Figure C (Etonogestrel 09)
FDA Label Image

Figure D (Etonogestrel 10)

Figure D (Etonogestrel 10)
FDA Label Image

Figure E (Etonogestrel 11)

Figure E (Etonogestrel 11)
FDA Label Image

Figure F (Etonogestrel 12)

Figure F (Etonogestrel 12)
The text describes a medication in the form of a vaginal ring that contains a combination of etonogestrel and ethinyl estradiol.*
FDA Label Image

Figure G (Etonogestrel 13)

Figure G (Etonogestrel 13)
FDA Label Image

Figure H (Etonogestrel 14)

Figure H (Etonogestrel 14)
FDA Label Image

Figure I (Etonogestrel 15)

Figure I (Etonogestrel 15)
FDA Label Image

Figure J (Etonogestrel 16)

Figure J (Etonogestrel 16)
FDA Label Image

Principal Display Panel (3 Ring Pouch Box)

Principal Display Panel (3 Ring Pouch Box)
This is a description for a vaginal ring contraceptive medication package. The package has a tamper-evident seal and an area reserved for 2D serialization barcode, serial number, expiry, and lot. The medication should be stored refrigerated between 2-8°C and kept out of the reach of children. The medication is intended to prevent pregnancy, but does not protect against HIV infection (AIDS) and other sexually transmitted diseases. Each ring contains 117 mg etonogestrel and 2.7 mg ethinyl estradiol as active ingredients and ethylene vinylacetat copomer and magnesium stearate as an excipient. The product should not be exposed to direct sunlight or temperature above 30°C (96°F). The medication should be dispensed to a patient within four months from the date of dispensing or the expiration date, whichever comes first. The packaging includes a sachet pouch with an expiration date and a label for placement on the medication. The product is manufactured by Praseo Laboratories in the USA and Organon & Co. I in The Netherlands. For any product information, the user can call 865-525-0686.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.